Given the critical role of the tumor microenvironment (TME) in resistance to therapy in vivo, we hypothesized that extrinsic factors might be involved in the resistance mechanism of ETP-ALL to LSD1 inhibitors (LSD1i). Here, KDM1A is linked to neoplasm.